SRRM2 haploinsufficiency drives SynGAP-γ reduction, Agap3 mis-splicing, and oligodendrocyte deficits in a mouse model of schizophrenia

This study demonstrates that SRRM2 haploinsufficiency drives schizophrenia-related phenotypes in mice by causing widespread gene expression changes, specific synaptic protein dysregulation (including SynGAP-γ reduction and Agap3 mis-splicing), and oligodendrocyte deficits that impair myelination.

The Gist

Imagine your brain is a massive, bustling city. For this city to function smoothly, it needs two main things: construction crews that build and maintain the roads and buildings, and traffic controllers that ensure the right messages get to the right places at the right time.

This paper is about a specific "traffic controller" named SRRM2. In people with schizophrenia and some neurodevelopmental disorders, this controller is often missing a piece of its toolkit (a condition scientists call "haploinsufficiency"). The researchers wanted to know: What happens to the brain city when this controller isn't working at full capacity?

Here is what they discovered, broken down into simple stories:

1. The "Instruction Manual" Glitch

Think of SRRM2 as the foreman in a library who helps organize the instruction manuals (DNA) for building proteins. When the foreman is understaffed (because the mouse only has one working copy of the gene instead of two), the library gets messy.

• The Result: The city's construction crews start reading the wrong pages. They build things that are too big, too small, or just plain wrong. This mess affects everything from how brain cells talk to each other (synapses) to how they generate energy (mitochondria). It's like a power plant suddenly trying to run on the wrong fuel.

2. The Broken "SynGAP" Switch and the "Agap3" Overload

One of the most important jobs in the brain is managing the "switches" that let neurons talk. A key protein called SynGAP acts like a volume knob for these conversations.

• The Problem: In the SRRM2-deficient mice, the brain stops making the "gamma" version of this volume knob. It's like someone took the volume knob off the radio.
• The Side Effect: At the same time, a protein called Agap3 (which usually works with SynGAP) starts piling up like a traffic jam. Without the volume knob to regulate it, this traffic jam gets worse, disrupting the clear flow of information between brain cells.
• The Human Connection: The researchers even tested this on human brain cells grown in a lab (from stem cells), and they saw the exact same traffic jam. This proves the problem isn't just in mice; it's a real human issue too.

3. The "Road Crew" Goes on Strike

The brain also needs oligodendrocytes. Think of these as the road crews that lay down the asphalt (myelin) on the highways. Myelin is the protective coating that makes electrical signals travel fast.

• The Discovery: In the mice with the SRRM2 problem, the number of these road crews dropped significantly, especially in the "striatum" (a busy downtown district of the brain).
• The Consequence: Without enough crews, the roads (myelin) are thin and patchy. Messages travel slowly or get lost. This is a bit like trying to drive a race car on a dirt path full of potholes.

4. How the City Behaves

Because the roads are bad and the radio signals are garbled, the mice started acting differently:

• Less Energy: They didn't move around as much (reduced locomotor activity).
• Startle Issues: If you made a loud noise, they didn't react the way a healthy mouse would (impaired startle response).
• Sleep Problems: When the researchers looked at their brain waves (EEG), they noticed the mice were missing "sleep spindles." These are little bursts of brain activity that happen during sleep and help the brain process memories. Interestingly, humans with schizophrenia often have the exact same missing sleep spindles.

The Big Picture

This paper connects the dots between a missing piece of a genetic "foreman" (SRRM2) and the symptoms of schizophrenia. It shows that when SRRM2 is weak:

1. The brain's instruction manuals get scrambled.
2. Critical communication switches break, causing traffic jams.
3. The road crews (myelin) disappear, slowing down brain traffic.

It's not just one thing going wrong; it's a chain reaction that starts with a tiny genetic glitch and ends with the whole city of the brain struggling to function. This gives scientists new targets to look at when trying to fix these disorders.

Technical Summary

Technical Summary: SRRM2 Haploinsufficiency in Schizophrenia Pathogenesis

1. Problem Statement

Rare loss-of-function (LoF) variants in the SRRM2 gene, which encodes a nuclear speckle scaffold and essential splicing factor, are strongly associated with schizophrenia and neurodevelopmental disorders. Despite this genetic link, the specific molecular and cellular mechanisms by which SRRM2 haploinsufficiency (a 50% reduction in gene dosage) disrupts brain function and leads to neuropsychiatric phenotypes remain largely undefined. This study aims to bridge that gap by characterizing the downstream consequences of reduced SRRM2 levels on gene expression, RNA splicing, cellular composition, and behavior.

2. Methodology

The researchers employed a multi-modal approach combining genetic modeling, transcriptomics, proteomics, and behavioral/physiological assays:

• Animal Model: Utilized Srrm2+/- mice (heterozygous knockout) to model human haploinsufficiency.
• Omics Analysis: Conducted large-scale gene expression profiling across multiple brain regions to identify pathway-level disruptions in both neuronal and glial cells.
• Splicing and Protein Analysis: Investigated specific alterations in RNA splicing and protein abundance, focusing on postsynaptic density proteins.
• Human Cell Models: Validated findings using human iPSC-derived neurons with SRRM2 deficiency to assess the conservation of splicing defects across species.
• Cellular Quantification: Analyzed cell type proportions, specifically focusing on oligodendrocytes, and measured myelin-related mRNA and protein levels.
• Behavioral and Physiological Phenotyping:
  • Behavior: Assessed locomotor activity and prepulse inhibition (startle responses).
  • Electrophysiology: Recorded EEG to analyze sleep architecture, specifically sleep spindles.

3. Key Contributions

This study provides the first comprehensive mechanistic link between SRRM2 haploinsufficiency and schizophrenia pathology, identifying three distinct but interconnected pathological axes:

1. Transcriptomic Dysregulation: Mapping the broad impact of SRRM2 loss on DNA-binding, synaptic, translational, and mitochondrial pathways.
2. SynGAP-γ/Agap3 Axis: Defining a specific splicing defect where the reduction of SRRM2 leads to a decrease in the SynGAP-γ isoform and a compensatory or pathological elevation of its interactor, Agap3.
3. Myelination Deficits: Establishing a direct link between SRRM2 loss and oligodendrocyte dysfunction, a feature often overlooked in synaptic-focused schizophrenia models.

4. Detailed Results

A. Transcriptomic and Pathway Alterations
Srrm2+/- mice exhibited widespread changes in gene expression across multiple brain regions. These changes were not limited to a single cell type but affected both neurons and glia. Key disrupted pathways included:

• DNA-binding functions.
• Synaptic transmission and plasticity.
• Protein translation machinery.
• Mitochondrial function and energy metabolism.

B. Synaptic Splicing Dysregulation (The Core Mechanism)
The study identified a critical splicing defect involving the SynGAP gene (a key regulator of synaptic plasticity):

• Reduction of SynGAP-γ: The specific gamma isoform of SynGAP was significantly reduced.
• Elevation of Agap3: The abundance of Agap3 (a known interactor of SynGAP) was elevated.
• Conservation: These specific splicing defects (specifically AGAP3 dysregulation) were recapitulated in human iPSC-derived neurons lacking SRRM2, confirming the translational relevance of the mouse model.

C. Oligodendrocyte and Myelin Deficits
A novel finding was the significant reduction in oligodendrocyte proportions, particularly within the striatum. This cellular deficit was accompanied by:

• Decreased expression of myelin-related mRNAs.
• Reduced levels of myelin-related proteins, suggesting impaired myelination.

D. Behavioral and Physiological Phenotypes
The molecular and cellular deficits translated into functional impairments resembling human schizophrenia:

• Behavior: Mice displayed reduced locomotor activity and impaired startle responses (indicating deficits in sensorimotor gating).
• EEG: Recordings revealed a significant reduction in sleep spindles, a hallmark electrophysiological feature observed in human patients with schizophrenia.

5. Significance

This research fundamentally advances the understanding of schizophrenia etiology by:

• Elucidating Mechanism: Moving beyond genetic association to define the causal chain: SRRM2 loss $\rightarrow$ splicing dysregulation (SynGAP-γ/Agap3) + oligodendrocyte deficits $\rightarrow$ synaptic and myelin dysfunction $\rightarrow$ behavioral/EEG phenotypes.
• Highlighting Glial Involvement: It underscores that schizophrenia pathology driven by splicing factors involves not just neurons, but also critical deficits in oligodendrocytes and myelination, offering new therapeutic targets.
• Validating Human Relevance: The conservation of AGAP3 splicing defects in human iPSC neurons strengthens the validity of the mouse model for drug discovery and mechanistic studies.
• Biomarker Potential: The identification of sleep spindle reduction as a physiological consequence of this specific genetic defect provides a potential biomarker for stratifying patients with SRRM2-related disorders.

In conclusion, the paper posits that SRRM2 haploinsufficiency drives neuropsychiatric disease through a dual mechanism of synaptic splicing dysregulation (specifically affecting the SynGAP-γ/Agap3 axis) and impaired oligodendrocyte-mediated myelination.